PRESS RELEASE | MINNEAPOLIS | March 2, 2026
Eyesafe Inc., the global leader in blue light management and standards for the consumer electronics industry, today announced the issuance of U.S. Patent No. 12,554,159, “Light Emission Reducing Compounds for Electronic Devices.” The patent, granted February 17, 2026, extends Eyesafe’s intellectual property position across the full spectrum of light management in consumer electronics – from selective blue light filtration to light conversion technologies that reshape display emissions for human health.
The Science Behind the Innovation
Not all approaches to blue light reduction are equal. Simple broad-spectrum blocking — the approach used by most competitors and software-based features like “Night Shift” – dims the display and produces a yellowish cast that degrades the user experience. Eyesafe technology takes a fundamentally different approach: selectively targeting the specific wavelength regions most associated with eye health and circadian disruption, while actively managing light across the full visible spectrum to preserve color fidelity and brightness.
Patent 12,554,159 protects key elements of this approach, including Eyesafe’s use of advanced absorbing compounds in polymer substrates that can be integrated across the display stack – from aftermarket screen protectors to OEM-embedded display layers. The patent’s 22 claims encompass selective spectral filtration across the blue light hazard region and circadian-sensitive wavelengths, as well as light management in additional spectral regions that enable the color balancing and performance preservation that define Eyesafe’s technology advantage.
Expanding Coverage: From Filtration to Conversion
This patent is part of a broader Eyesafe IP strategy that extends well beyond traditional blue light blocking. Eyesafe’s portfolio now spans two complementary approaches to light management for healthier displays:
Selective Spectral Filtration: Eyesafe’s core Double Notch technology targets specific narrow wavelength bands simultaneously, achieving precise spectral shaping that reduces harmful light while enhancing display color saturation. Patent 12,554,159 strengthens this family with additional claims covering multiple polymer substrates, quantified filtration thresholds, and integration methods for both OEM and aftermarket applications.
Light Conversion Technology: Eyesafe also holds issued patents covering light emission modification and up-conversion technology. Rather than simply absorbing harmful wavelengths, these innovations absorb high-energy blue light and convert it into less harmful longer wavelengths – effectively reshaping the display’s spectral output at the source. This approach enables manufacturers to achieve even greater flexibility in balancing health impact with display performance requirements across backlight units and the broader optical stack.
Together, these two technology pillars — filtration and conversion — give Eyesafe an IP position that covers how the industry manages harmful light emissions today and the technical pathways it will pursue in the future.
A Growing IP Fortress Across Display Technologies
Patent 12,554,159 is the latest issued in a patent family tracing back to 2014, now encompassing multiple issued U.S. patents and active filings across more than ten international jurisdictions. But the Glass/In-Display Notch family is just one layer of a comprehensive IP estate. Eyesafe’s portfolio now includes distinct patent families covering:
Selective filtration of blue light in display substrates, films, and optical layers — the foundation of Eyesafe’s screen protection and display technology licensing businesses.
Color filter enhancements using dye-doped resins for precise spectral control with minimal color shift — extending coverage into next-generation display architectures and ophthalmic applications.
OLED-optimized filtration targeting the melanopic (circadian) blue light region, addressing the spectral differences between LCD and OLED displays as the mobile market transitions to emissive display technologies.
Light conversion and backlight modification covering optical stack architectures that incorporate absorbers and conversion materials to reshape emissions before they reach the viewer.
Software-integrated light management combining physical filters with intelligent detection, exposure tracking, and adaptive spectral control.
Emerging therapeutic light applications — including red light and photobiomodulation technologies that explore the use of beneficial wavelengths delivered through electronic devices and eyewear.
Combined with an exclusive worldwide license to foundational spectral filtration patents and a proprietary library of over 40 formulations that serve as operational trade secrets, Eyesafe maintains the most comprehensive intellectual property position in the display health technology space — with more than 50 active IP assets across key global jurisdictions.
Protecting Partners and Industry Leadership
“Our IP strategy is built to protect the entire ecosystem – from the OEMs integrating Eyesafe technology into their displays to the accessory partners bringing our screen protection to consumers,” said Justin Barrett, CEO of Eyesafe. “This patent reinforces what we’ve been building for over a decade: the most comprehensive and defensible technology platform in display health. From selective filtration to light conversion to emerging therapeutic wavelengths, we are ensuring that the companies who invest in healthier displays are backed by IP that covers the full spectrum of where this industry is headed.”
Eyesafe continues to actively expand its patent portfolio with pending applications in the United States and internationally, ensuring coverage keeps pace with the industry’s evolution toward OLED, AR/VR, and adaptive display technologies. The company has a proven track record of enforcing its IP, having successfully addressed infringement concerns with multiple market participants, and continues to maintain the highest-performing blue light management products available.
Learn more about Eyesafe® Technology at Eyesafe.com and Eyesafe patents at eyesafe.com/patents.
About Eyesafe
Eyesafe brings together world leaders in healthcare and consumer electronics to advocate solutions and standards for high-energy visible light (HEVL) and color performance. With innovative technology to reduce HEVL in consumer electronics, Eyesafe helps re-design displays for human health. Eyesafe technology and standards were developed by a world-class team of eye doctors, engineers, and scientists, with decades of experience in electronics, display materials, and light management. https://eyesafe.com